Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
CRNX Crinetics
- 53.600
- +0.860+1.63%
Close Dec 20 16:00 ET
- 53.600
- 0.0000.00%
Post 16:00 ET
4.97BMarket Cap-14.49P/E (TTM)
54.250High51.730Low1.94MVolume52.280Open52.740Pre Close103.85MTurnover2.12%Turnover RatioLossP/E (Static)92.74MShares62.53052wk High5.97P/B4.90BFloat Cap33.67052wk Low--Dividend TTM91.47MShs Float62.530Historical High--Div YieldTTM4.78%Amplitude10.630Historical Low53.517Avg Price1Lot Size
About Crinetics Company
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.
Company Profile
SymbolCRNX
Company NameCrinetics
Listing DateJul 18, 2018
Issue Price17.00
Founded2008
CEODr. R. Scott Struthers, PhD
MarketNASDAQ
Employees290
Fiscal Year Ends12-31
Address6055 Lusk Boulevard
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-450-6464
Websitehttp://www.crinetics.com
Company Executives
- Name
- Position
- Salary
- Dr. R. Scott Struthers, PhD
- Director, President and Chief Executive Officer
- 5.75M
- Isabel Kalofonos
- Chief Commercial Officer
- --
- Marc J.S. Wilson
- Chief Financial Officer and Principal Accounting Officer
- 2.51M
- Dr. Dana Pizzuti, M.D.
- Chief Medical and Development Officer
- --
- Dr. Stephen F. Betz, PhD
- Chief Scientific Officer
- 2.50M
- Jeff E. Knight
- Chief Operating Officer
- 2.36M
- Dr. Wendell D. Wierenga,PhD
- Chairman of the Board
- 375.31K
- Dr. Camille L. Bedrosian,M.D.
- Independent Director
- 339.56K
- Dr. Weston Nichols, PhD
- Independent Director
- 338.56K
- Dr. Rogerio Vivaldi Coelho, M.B.A.,M.D.
- Independent Director
- 338.56K
- Stephanie S. Okey, M.S.
- Independent Director
- 342.31K
- Caren Deardorf
- Independent Director
- 330.06K
- Matthew K. Fust
- Independent Director
- 348.56K
- Dr. Alan Krasner,M.D.
- Chief Endocrinologist
- 2.16M
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.